Considerations To Know About Is ABBV-744 effective for hematologic cancers?
In Phase C, contributors will get ABBV-744 and oral navitoclax. In Phase D, individuals will acquire ABBV-744 and ruxolitinib. Individuals will get treatment until ailment progression or the individuals are unable to tolerate the study drugs.Overall, our current work highlights the potential utilization of ARV-825 in combination with TAM. While ABB